Follow
Yong Sheng
Yong Sheng
Dr of cancer biology, Mater Research Institute - UQ
Verified email at mater.uq.edu.au
Title
Cited by
Cited by
Year
High fat diets induce colonic epithelial cell stress and inflammation that is reversed by IL-22
M Gulhane, L Murray, R Lourie, H Tong, YH Sheng, R Wang, A Kang, ...
Scientific reports 6 (1), 28990, 2016
3172016
MUC1 Limits Helicobacter pylori Infection both by Steric Hindrance and by Acting as a Releasable Decoy
SK Lindén, YH Sheng, AL Every, KM Miles, EC Skoog, THJ Florin, ...
PLoS pathogens 5 (10), e1000617, 2009
3102009
Mucins in inflammatory bowel diseases and colorectal cancer
YH Sheng, SZ Hasnain, THJ Florin, MA McGuckin
Journal of gastroenterology and hepatology 27 (1), 28-38, 2012
2092012
MUC1 and MUC13 differentially regulate epithelial inflammation in response to inflammatory and infectious stimuli
YH Sheng, S Triyana, R Wang, I Das, K Gerloff, TH Florin, P Sutton, ...
Mucosal immunology 6 (3), 557-568, 2013
1382013
The MUC13 cell-surface mucin protects against intestinal inflammation by inhibiting epithelial cell apoptosis
YH Sheng, R Lourie, SK Lindén, PL Jeffery, D Roche, TV Tran, CW Png, ...
Gut 60 (12), 1661-1670, 2011
1282011
Epitope studies with anti-β2-glycoprotein I antibodies from autoantibody and immunized sources
SW Reddel, YX Wang, YH Sheng, SA Krilis
Journal of autoimmunity 15 (2), 91-96, 2000
1182000
Antibody to the dendritic cell surface activation antigen CD83 prevents acute graft-versus-host disease
J Wilson, H Cullup, R Lourie, Y Sheng, A Palkova, KJ Radford, ...
Journal of Experimental Medicine 206 (2), 387-398, 2009
852009
MUC13 protects colorectal cancer cells from death by activating the NF-κB pathway and is a potential therapeutic target
YH Sheng, Y He, SZ Hasnain, R Wang, H Tong, DT Clarke, R Lourie, ...
Oncogene 36 (5), 700-713, 2017
822017
Airway mucus hyperconcentration in non–cystic fibrosis bronchiectasis
KA Ramsey, ACH Chen, G Radicioni, R Lourie, M Martin, A Broomfield, ...
American journal of respiratory and critical care medicine 201 (6), 661-670, 2020
762020
MUC13 overexpression in renal cell carcinoma plays a central role in tumor progression and drug resistance
Y Sheng, CP Ng, R Lourie, ET Shah, Y He, KY Wong, I Seim, I Oancea, ...
International journal of cancer 140 (10), 2351-2363, 2017
422017
Immunosuppressive human anti-CD83 monoclonal antibody depletion of activated dendritic cells in transplantation
TA Seldon, R Pryor, A Palkova, ML Jones, ND Verma, M Findova, K Braet, ...
Leukemia 30 (3), 692-700, 2016
322016
CDCP1 enhances Wnt signaling in colorectal cancer promoting nuclear localization of β-catenin and E-cadherin
Y He, CM Davies, BS Harrington, L Hellmers, Y Sheng, A Broomfield, ...
Oncogene 39 (1), 219-233, 2020
312020
Techniques for assessment of interactions of mucins with microbes and parasites in vitro and in vivo
YH Sheng, SZ Hasnain, CW Png, MA McGuckin, SK Lindén
Mucins: Methods and Protocols, 297-312, 2012
82012
Developing a Therapeutic Anti-Dendritic Cell Antibody to Prevent Graft Versus Host Disease.
D Hart, T Seldon, M Jones, Y Sheng, A Palkova, H Cullup, T Munro, ...
Blood, The Journal of the American Society of Hematology 114 (22), 3554-3554, 2009
12009
Targeted interleukin-22 therapy improves glycemic control, steatohepatitis, and fibrosis in experimental models of metabolic dysfunction-associated steatohepatitis
H Sajiir, S Keshvari, KY Wong, D Borg, A Mueller, M Moniruzzaman, ...
Journal of Gastroenterology and Hepatology 38, 37-37, 2023
2023
Thioguanine prevents colitis-associated cancer via beta-catenin signaling in intestinal epithelial cells independently of immunosuppression and autophagy
Y Sheng, R Giri, J Davies, V Schreiber, S Alabbas, R Movva, Y He, A Wu, ...
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 35, 106-106, 2020
2020
Characterisation of Human CD83 Expression on Immune Cells and Their Targeting with CD83 Antibodies to Prevent Graft Versus Host Disease in Allogeneic Haematopoietic Cell …
DNJ Hart, X Ju, Z Elgundi, N Verma, P Silveira, P Fromm, R Alingcastre, ...
Blood 126 (23), 3081, 2015
2015
The human monoclonal antibody 3C12C targeting activated dendritic cells is a potential new immunosuppressive agent
P Silveira, ND Verma, DJ Munster, TA Seldon, Y Sheng, ML Jones, ...
TRANSPLANTATION 99 (11), S142-S143, 2015
2015
The Human Monoclonal Antibody 3C12C, Targeting Activated Dendritic Cells Is a Potential New Immunosuppressive Agent
ND Verma, D Munster, T Seldon, YH Sheng, M Jones, T Munro, S Mahler, ...
Biology of Blood and Marrow Transplantation 21 (2), S330-S331, 2015
2015
CD83 Expression On Human Immune Cells as a Target for Immunosuppression
DNJ Hart, Z Elgundi, J Xinsheng, ND Verma, PA Silveira, PD Fromm, ...
Immunology and Cell Biology 93 (9), A8-A8, 2015
2015
The system can't perform the operation now. Try again later.
Articles 1–20